FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Clomethiazole 31.5mg/ml oral solution sugar free (Neon Healthcare Ltd) 300 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ifosfamide 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 250mg/5ml oral solution sugar free (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 250mg/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ifosfamide 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 250mg/5ml oral solution sugar free (Alliance Healthcare (Distribution) Ltd) 300 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 250mg/5ml oral solution sugar free (A A H Pharmaceuticals Ltd) 300 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dichlorobenzyl alcohol 1.29mg pastilles sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Antiseptic Sore Mouth 1.29mg pastilles (The Boots Company Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dichlorobenzyl alcohol 1.29mg pastilles sugar free 30 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Antiseptic Sore Mouth 1.29mg pastilles (The Boots Company Plc) 30 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye drops (Doncaster Pharmaceuticals Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Guanethidine 10mg/1ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Guanethidine 10mg/1ml solution for injection ampoules (Alliance Healthcare (Distribution) Ltd) 5 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 2% gel 5 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 2% gel (Special Order) 5 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Waymade Healthcare Plc) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Doncaster Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Artelac Single Dose Unit 0.32% eye drops 0.5ml unit dose (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
NiQuitin Minis Orange 1.5mg lozenges (GlaxoSmithKline Consumer Healthcare) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Artelac Single Dose Unit 0.32% eye drops 0.5ml unit dose (Waymade Healthcare Plc) 30 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
NiQuitin Minis Orange 1.5mg lozenges (GlaxoSmithKline Consumer Healthcare) 20 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
NiQuitin Minis Orange 1.5mg lozenges (GlaxoSmithKline Consumer Healthcare) 60 lozenge 3 x 20 lozenges VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets mixed berries (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets tropical (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets mixed berries (Bayer Plc) 15 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets mixed berries (Bayer Plc) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Berocca effervescent tablets tropical (Bayer Plc) 15 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnitrope SurePal 5 5mg/1.5ml solution for injection cartridges (Sandoz Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnitrope SurePal 5 5mg/1.5ml solution for injection cartridges (Sandoz Ltd) 5 cartridge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely bifonazole 10 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Rennie Dual Action chewable tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Canesten AF Once Daily bifonazole 1% cream (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bifonazole 1% cream 15 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rennie Dual Action chewable tablets (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Rennie Dual Action chewable tablets 12 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bifonazole 1% cream 20 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Rennie Dual Action chewable tablets 24 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Canesten AF Once Daily bifonazole 1% cream (Bayer Plc) 15 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Canesten AF Once Daily bifonazole 1% cream (Bayer Plc) 20 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rennie Dual Action chewable tablets (Bayer Plc) 12 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rennie Dual Action chewable tablets (Bayer Plc) 24 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levothyroxine sodium 100micrograms/5ml oral solution sugar free (Mercury Pharma Group Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Urgotul SSD dressing 10cm x 12cm (Urgo Ltd) 16 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Urgotul SSD dressing 15cm x 20cm (Urgo Ltd) 16 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levothyroxine sodium 100micrograms/5ml oral solution sugar free (Mercury Pharma Group Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely chlorpromazine (as chlorpromazine hydrochloride) 100 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Droplet hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge (Cambridge Sensors Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 100mg suppositories (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GlucoRx FinePoint hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge (GlucoRx Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 100mg suppositories 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 100mg suppositories 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorazin 100mg suppositories (G. Streuli & Co. AG) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GlucoRx FinePoint hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge (GlucoRx Ltd) 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 100mg suppositories (Special Order) 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorazin 100mg suppositories (G. Streuli & Co. AG) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Droplet hypodermic insulin needles for pre-filled / reusable pen injectors screw on 10mm/29gauge (Cambridge Sensors Ltd) 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ranibizumab 2.3mg/0.23ml solution for inection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (PI) (Waymade Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ranibizumab 2.3mg/0.23ml solution for inection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lucentis 2.3mg/0.23ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Necessity Supplies Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lucentis 2.3mg/0.23ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Doncaster Pharmaceuticals Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (PI) (Waymade Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Necessity Supplies Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Mawdsley-Brooks & Company Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Lexon (UK) Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dovobet ointment (Sigma Pharmaceuticals Plc) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 2% gel (Drug Tariff Special Order) 15 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Argipressin 20units/1ml solution for injection ampoules (Mercury Pharma Group Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benzhexol hydrochloride 5mg/5mL syrup VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cod liver oil 294mg capsules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cod liver oil 294mg capsules 120 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Broflex 5mg/5ml syrup (Alliance Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Elive Cod Liver Oil 294mg capsules (Ennogen Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml syrup (Rosemont Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cod liver oil 294mg capsules 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Seven Seas Cod Liver Oil capsules (Seven Seas Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cod liver oil 294mg capsules 30 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cod liver oil 294mg capsules 500 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
BD AutoShield Duo hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge (Becton, Dickinson UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 54 of 86 Next End

This concept is not in any reference sets

Back to Start